- New LOI would allow the company to join development of a wide range of hemp-based medicinal products
- Neutra would also gain access to a cultivation license and a research license to examine the role of cannabinoids as antioxidants and neuro-protectants
- CBD sales in the U.S. expected to exceed $20 billion by 2024; hemp-based CBD product sales reached $390 in 2018 and are expected to more than triple over the next couple of years
Early-stage research and development company Neutra Corp. (OTC: NTRR) executed a Letter of Intent (LOI) that could lead to the joint development of a vast selection of additional hemp-based medicinal products on the booming CBD market, according to a company press release (http://cnw.fm/hUH7u).
Neutra intends to conclude an agreement with Orgaceutical Co, based in Harrisburg, PA. If executed as planned, the agreement would provide Neutra with access to Orgaceutical’s formal research findings into the potential benefits of cannabinoids as antioxidants and neuro-protectants. Neutra, who is expanding into hemp cultivation and…
NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]